Craig Hanson, MD
Urogynecology and Reconstructive Pelvic Surgery · Hicksville, OHNPI 1578600565
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Coloplast at 39.6% of the total. Reporting peaked in 2019 at $3,849 and has fallen 91.8% since, to $317 in 2025.
Across 124 payments — averaging $73.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$4K
- Boston Scientific$2K
- Axonics, Inc.$2K
- Medtronic$629
- AbbVie$287
- Femselect Inc.$260
- plus $972 from 17 others
Across 22 payments — averaging $2319.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$51K
What the payments were for
- Travel & lodging$2,98533%
- Food & beverage$4,00344%
- Education$2,11923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 21 | $3,606 |
| Boston Scientific | 11 | $1,735 |
| Axonics, Inc. | 20 | $1,618 |
| Medtronic(2 entities) | 12 | $629 |
| AbbVie | 13 | $287 |
| Femselect Inc. | 3 | $260 |
| Sumitomo Pharma America, Inc. | 8 | $215 |
| Therapeuticsmd, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 7 | $110 |
| Amgen | 3 | $108 |
| Hologic Sales And Service, LLC | 4 | $73 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Merck | 4 | $55 |
| Pfizer | 3 | $50 |
| Exeltis, USA Inc. | 2 | $31 |
| Urogen Pharma, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $27 |
| Shield Therapeutics Inc | 1 | $19 |
| Intuitive Surgical | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $12 |
| Organon | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,108 in reported general payments places this provider in the 75th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
See all urogynecology and reconstructive pelvic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 72 | $48,712 |
| MyrbetriqMirabegron | 17 | $14,147 |
| Estradiol | 87 | $3,452 |
| Ciprofloxacin Hcl | 53 | $600 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $515 |
| Cephalexin | 36 | $451 |
| Desmopressin Acetate | 18 | $441 |
| Triamcinolone Acetonide | 33 | $282 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $137 |
| Fluconazole | 24 | $105 |
| Ondansetron Hcl | 12 | $90 |
| Alendronate Sodium | 14 | $82 |
| Tramadol Hcl | 23 | $64 |
| ProgesteroneProgesterone, Micronized | 11 | $55 |
| Levofloxacin | 20 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $215 | $48,71272 claims |
| Astellas Pharma US IncMyrbetriq | $110 | $14,14717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
Other urogynecology and reconstructive pelvic surgery in Hicksville
- Costas ApostolisStrongsville$982K
- Mickey KarramWest Chester$127K
- Sangeeta MahajanMayfield Hts$48K
- Emily SlopnickCleveland$37K
- Mitesh ParekhZanesville$33K
- Andrew CroakMaumee$26K
- Ly Hoang RobertsCleveland$23K
- Marie ParaisoCleveland$20K
- Omer AnisCleveland$17K
- Nadine KassisToledo$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.